Ontology type: schema:ScholarlyArticle
1976-07
AUTHORSTHOMAS C. SPELSBERG, ROBERT A. WEBSTER, GEORGE M. PIKLER
ABSTRACTSTEROID hormones accumulate in their respective target cells due to the presence of “receptor” proteins which bind the steroid with high affinity and specificity1–4. It seems that the steroid–receptor complexes then migrate and bind to nuclear chromatin2–5. Within about 15 min there is an alteration in transcription which is followed after 2 h by the appearance of specific messenger RNAs6–9. At present, the mechanism by which steroids alter gene expression is obscure. The group in our laboratory is attempting to identify the nuclear (or chromatin) component which binds the progesterone-receptor (P–R) complex because it is possible that the macromolecules involved are also involved in the steroid-induced modifications of gene expression. We have demonstrated recently more than one class of binding sites in chick oviduct nuclei in vivo and in hen oviduct nuclei and chromatin in vitro10–12,13. The highest affinity class of sites, representing 5,000–10,000 sites per cell nucleus, is suspected to be the biologically important class, because: (1) it is the only class which binds P–R in vitro in physiological ionic conditions (0.15–0.20 M KCl); (2) it is the only class bound in vivo when the steroid is at physiological levels in the serum; (3) binding to whole chromatin is tissue-specific, found only in oviduct chromatin, and (4) when these sites are saturated in vivo with the P–R, maximal responses of the RNA polymerase I and II activities are observed in vitro. Although additional nuclear binding to the sites of weaker affinity can be achieved in vivo, this causes no further alteration of polymerase activities13. We have also found that the low ionic conditions (0.01–0.05 M KCl), often used in binding assays, result in a pattern of nuclear binding which is non-saturable and shows no tissue specificity. When the ionic strength of the binding assays is increased to 0.15 M or 0.2 M KCl, there is a saturable, tissue-specific binding which measures selectively only the highest affinity class of binding sites10–12. We now present evidence which suggests that one fraction of the non-histone protein (NHP) (called AP3) is involved in the high affinity binding of P–R to the chromatin of the progesterone target tissue—oviduct—while other fractions (AP1 or AP2) are involved in masking these binding sites. We also present data which indicate that the high affinity binding sites are present but completely masked in non-target tissues. More... »
PAGES65-67
http://scigraph.springernature.com/pub.10.1038/262065a0
DOIhttp://dx.doi.org/10.1038/262065a0
DIMENSIONShttps://app.dimensions.ai/details/publication/pub.1018904914
PUBMEDhttps://www.ncbi.nlm.nih.gov/pubmed/180427
JSON-LD is the canonical representation for SciGraph data.
TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT
[
{
"@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json",
"about": [
{
"id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/06",
"inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/",
"name": "Biological Sciences",
"type": "DefinedTerm"
},
{
"id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11",
"inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/",
"name": "Medical and Health Sciences",
"type": "DefinedTerm"
},
{
"id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/0601",
"inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/",
"name": "Biochemistry and Cell Biology",
"type": "DefinedTerm"
},
{
"id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103",
"inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/",
"name": "Clinical Sciences",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Animals",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Binding Sites",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Chickens",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Chromatin",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Deoxyribonucleoproteins",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Erythrocytes",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Female",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Nucleoproteins",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Oviducts",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Progesterone",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Receptors, Cell Surface",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Spleen",
"type": "DefinedTerm"
}
],
"author": [
{
"affiliation": {
"alternateName": "Department of Molecular Medicine, Mayo Clinic and Graduate School of Medicine, 55901, Rochester, Minnesota",
"id": "http://www.grid.ac/institutes/grid.66875.3a",
"name": [
"Department of Molecular Medicine, Mayo Clinic and Graduate School of Medicine, 55901, Rochester, Minnesota"
],
"type": "Organization"
},
"familyName": "SPELSBERG",
"givenName": "THOMAS C.",
"id": "sg:person.01113450652.09",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01113450652.09"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Department of Molecular Medicine, Mayo Clinic and Graduate School of Medicine, 55901, Rochester, Minnesota",
"id": "http://www.grid.ac/institutes/grid.66875.3a",
"name": [
"Department of Molecular Medicine, Mayo Clinic and Graduate School of Medicine, 55901, Rochester, Minnesota"
],
"type": "Organization"
},
"familyName": "WEBSTER",
"givenName": "ROBERT A.",
"id": "sg:person.077352642.31",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.077352642.31"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Department of Molecular Medicine, Mayo Clinic and Graduate School of Medicine, 55901, Rochester, Minnesota",
"id": "http://www.grid.ac/institutes/grid.66875.3a",
"name": [
"Department of Molecular Medicine, Mayo Clinic and Graduate School of Medicine, 55901, Rochester, Minnesota"
],
"type": "Organization"
},
"familyName": "PIKLER",
"givenName": "GEORGE M.",
"id": "sg:person.0103213742.25",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0103213742.25"
],
"type": "Person"
}
],
"datePublished": "1976-07",
"datePublishedReg": "1976-07-01",
"description": "STEROID hormones accumulate in their respective target cells due to the presence of \u201creceptor\u201d proteins which bind the steroid with high affinity and specificity1\u20134. It seems that the steroid\u2013receptor complexes then migrate and bind to nuclear chromatin2\u20135. Within about 15 min there is an alteration in transcription which is followed after 2 h by the appearance of specific messenger RNAs6\u20139. At present, the mechanism by which steroids alter gene expression is obscure. The group in our laboratory is attempting to identify the nuclear (or chromatin) component which binds the progesterone-receptor (P\u2013R) complex because it is possible that the macromolecules involved are also involved in the steroid-induced modifications of gene expression. We have demonstrated recently more than one class of binding sites in chick oviduct nuclei in vivo and in hen oviduct nuclei and chromatin in vitro10\u201312,13. The highest affinity class of sites, representing 5,000\u201310,000 sites per cell nucleus, is suspected to be the biologically important class, because: (1) it is the only class which binds P\u2013R in vitro in physiological ionic conditions (0.15\u20130.20 M KCl); (2) it is the only class bound in vivo when the steroid is at physiological levels in the serum; (3) binding to whole chromatin is tissue-specific, found only in oviduct chromatin, and (4) when these sites are saturated in vivo with the P\u2013R, maximal responses of the RNA polymerase I and II activities are observed in vitro. Although additional nuclear binding to the sites of weaker affinity can be achieved in vivo, this causes no further alteration of polymerase activities13. We have also found that the low ionic conditions (0.01\u20130.05 M KCl), often used in binding assays, result in a pattern of nuclear binding which is non-saturable and shows no tissue specificity. When the ionic strength of the binding assays is increased to 0.15 M or 0.2 M KCl, there is a saturable, tissue-specific binding which measures selectively only the highest affinity class of binding sites10\u201312. We now present evidence which suggests that one fraction of the non-histone protein (NHP) (called AP3) is involved in the high affinity binding of P\u2013R to the chromatin of the progesterone target tissue\u2014oviduct\u2014while other fractions (AP1 or AP2) are involved in masking these binding sites. We also present data which indicate that the high affinity binding sites are present but completely masked in non-target tissues.",
"genre": "article",
"id": "sg:pub.10.1038/262065a0",
"isAccessibleForFree": false,
"isPartOf": [
{
"id": "sg:journal.1018957",
"issn": [
"0028-0836",
"1476-4687"
],
"name": "Nature",
"publisher": "Springer Nature",
"type": "Periodical"
},
{
"issueNumber": "5563",
"type": "PublicationIssue"
},
{
"type": "PublicationVolume",
"volumeNumber": "262"
}
],
"keywords": [
"non-histone proteins",
"gene expression",
"RNA polymerase I",
"oviduct nuclei",
"progesterone-receptor complex",
"tissue-specific binding",
"chromosomal proteins",
"steroid-receptor complex",
"chromatin",
"physiological ionic conditions",
"polymerase I",
"tissue specificity",
"ionic conditions",
"whole chromatin",
"hen oviduct nuclei",
"high-affinity binding",
"oviduct chromatin",
"cell nuclei",
"respective target cells",
"low ionic conditions",
"progesterone target",
"protein",
"binding sites",
"nuclear components",
"physiological levels",
"high-affinity binding sites",
"binding assays",
"binding",
"only class",
"affinity binding",
"affinity class",
"target cells",
"vivo",
"weak affinity",
"affinity binding sites",
"high affinity",
"expression",
"nuclear binding",
"steroid hormones",
"sites",
"high-affinity class",
"assays",
"transcription",
"nucleus",
"complexes",
"polymerase",
"further alterations",
"M KCl",
"affinity",
"binds",
"alterations",
"vitro10",
"important class",
"cells",
"receptors",
"migrate",
"macromolecules",
"target",
"tissue",
"mechanism",
"specificity",
"non-target tissues",
"modification",
"activity",
"hormone",
"class",
"patterns",
"fraction",
"response",
"ionic strength",
"conditions",
"presence",
"evidence",
"components",
"levels",
"maximal response",
"laboratory",
"KCl",
"present",
"steroids",
"appearance",
"data",
"serum",
"group",
"min",
"measures",
"strength"
],
"name": "Chromosomal proteins regulate steroid binding to chromatin",
"pagination": "65-67",
"productId": [
{
"name": "dimensions_id",
"type": "PropertyValue",
"value": [
"pub.1018904914"
]
},
{
"name": "doi",
"type": "PropertyValue",
"value": [
"10.1038/262065a0"
]
},
{
"name": "pubmed_id",
"type": "PropertyValue",
"value": [
"180427"
]
}
],
"sameAs": [
"https://doi.org/10.1038/262065a0",
"https://app.dimensions.ai/details/publication/pub.1018904914"
],
"sdDataset": "articles",
"sdDatePublished": "2022-08-04T16:49",
"sdLicense": "https://scigraph.springernature.com/explorer/license/",
"sdPublisher": {
"name": "Springer Nature - SN SciGraph project",
"type": "Organization"
},
"sdSource": "s3://com-springernature-scigraph/baseset/20220804/entities/gbq_results/article/article_134.jsonl",
"type": "ScholarlyArticle",
"url": "https://doi.org/10.1038/262065a0"
}
]
Download the RDF metadata as: json-ld nt turtle xml License info
JSON-LD is a popular format for linked data which is fully compatible with JSON.
curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1038/262065a0'
N-Triples is a line-based linked data format ideal for batch operations.
curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1038/262065a0'
Turtle is a human-readable linked data format.
curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1038/262065a0'
RDF/XML is a standard XML format for linked data.
curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1038/262065a0'
This table displays all metadata directly associated to this object as RDF triples.
218 TRIPLES
20 PREDICATES
127 URIs
117 LITERALS
19 BLANK NODES
Subject | Predicate | Object | |
---|---|---|---|
1 | sg:pub.10.1038/262065a0 | schema:about | N08e8db922bfa4a8dafbdcd475d6a78a5 |
2 | ″ | ″ | N0adcd6bd9b294023b576bed0fda979d6 |
3 | ″ | ″ | N3d62ddc7c16a4c3e90aadb783c25c7ba |
4 | ″ | ″ | N3e5953fb52454b2584a32b3b014608f8 |
5 | ″ | ″ | N5dcadfd71d174cdfa9431b91699158ff |
6 | ″ | ″ | N620555fdc00648c1970b588cad3b4b60 |
7 | ″ | ″ | N62f422f4710a4ca0a4a5435c63f0c109 |
8 | ″ | ″ | N8981a049410d4fc28142fa24d8c7ba4f |
9 | ″ | ″ | N90059206512e4db696aa5522e3e68ee3 |
10 | ″ | ″ | Ncb7e92096e0a4b5fa6ab155f2dafc3f7 |
11 | ″ | ″ | Nf1ebb43768b648c88254d0ae4a162ebc |
12 | ″ | ″ | Nf4580ad608f6411f8a9a49573d70a682 |
13 | ″ | ″ | anzsrc-for:06 |
14 | ″ | ″ | anzsrc-for:0601 |
15 | ″ | ″ | anzsrc-for:11 |
16 | ″ | ″ | anzsrc-for:1103 |
17 | ″ | schema:author | N8c60740ad9ab44cdb300b32e53bdc225 |
18 | ″ | schema:datePublished | 1976-07 |
19 | ″ | schema:datePublishedReg | 1976-07-01 |
20 | ″ | schema:description | STEROID hormones accumulate in their respective target cells due to the presence of “receptor” proteins which bind the steroid with high affinity and specificity1–4. It seems that the steroid–receptor complexes then migrate and bind to nuclear chromatin2–5. Within about 15 min there is an alteration in transcription which is followed after 2 h by the appearance of specific messenger RNAs6–9. At present, the mechanism by which steroids alter gene expression is obscure. The group in our laboratory is attempting to identify the nuclear (or chromatin) component which binds the progesterone-receptor (P–R) complex because it is possible that the macromolecules involved are also involved in the steroid-induced modifications of gene expression. We have demonstrated recently more than one class of binding sites in chick oviduct nuclei in vivo and in hen oviduct nuclei and chromatin in vitro10–12,13. The highest affinity class of sites, representing 5,000–10,000 sites per cell nucleus, is suspected to be the biologically important class, because: (1) it is the only class which binds P–R in vitro in physiological ionic conditions (0.15–0.20 M KCl); (2) it is the only class bound in vivo when the steroid is at physiological levels in the serum; (3) binding to whole chromatin is tissue-specific, found only in oviduct chromatin, and (4) when these sites are saturated in vivo with the P–R, maximal responses of the RNA polymerase I and II activities are observed in vitro. Although additional nuclear binding to the sites of weaker affinity can be achieved in vivo, this causes no further alteration of polymerase activities13. We have also found that the low ionic conditions (0.01–0.05 M KCl), often used in binding assays, result in a pattern of nuclear binding which is non-saturable and shows no tissue specificity. When the ionic strength of the binding assays is increased to 0.15 M or 0.2 M KCl, there is a saturable, tissue-specific binding which measures selectively only the highest affinity class of binding sites10–12. We now present evidence which suggests that one fraction of the non-histone protein (NHP) (called AP3) is involved in the high affinity binding of P–R to the chromatin of the progesterone target tissue—oviduct—while other fractions (AP1 or AP2) are involved in masking these binding sites. We also present data which indicate that the high affinity binding sites are present but completely masked in non-target tissues. |
21 | ″ | schema:genre | article |
22 | ″ | schema:isAccessibleForFree | false |
23 | ″ | schema:isPartOf | Ne08f99392e914c8496d4a792c41164c1 |
24 | ″ | ″ | Ne42f33d5b31043faa93bc8c9f4be8b17 |
25 | ″ | ″ | sg:journal.1018957 |
26 | ″ | schema:keywords | KCl |
27 | ″ | ″ | M KCl |
28 | ″ | ″ | RNA polymerase I |
29 | ″ | ″ | activity |
30 | ″ | ″ | affinity |
31 | ″ | ″ | affinity binding |
32 | ″ | ″ | affinity binding sites |
33 | ″ | ″ | affinity class |
34 | ″ | ″ | alterations |
35 | ″ | ″ | appearance |
36 | ″ | ″ | assays |
37 | ″ | ″ | binding |
38 | ″ | ″ | binding assays |
39 | ″ | ″ | binding sites |
40 | ″ | ″ | binds |
41 | ″ | ″ | cell nuclei |
42 | ″ | ″ | cells |
43 | ″ | ″ | chromatin |
44 | ″ | ″ | chromosomal proteins |
45 | ″ | ″ | class |
46 | ″ | ″ | complexes |
47 | ″ | ″ | components |
48 | ″ | ″ | conditions |
49 | ″ | ″ | data |
50 | ″ | ″ | evidence |
51 | ″ | ″ | expression |
52 | ″ | ″ | fraction |
53 | ″ | ″ | further alterations |
54 | ″ | ″ | gene expression |
55 | ″ | ″ | group |
56 | ″ | ″ | hen oviduct nuclei |
57 | ″ | ″ | high affinity |
58 | ″ | ″ | high-affinity binding |
59 | ″ | ″ | high-affinity binding sites |
60 | ″ | ″ | high-affinity class |
61 | ″ | ″ | hormone |
62 | ″ | ″ | important class |
63 | ″ | ″ | ionic conditions |
64 | ″ | ″ | ionic strength |
65 | ″ | ″ | laboratory |
66 | ″ | ″ | levels |
67 | ″ | ″ | low ionic conditions |
68 | ″ | ″ | macromolecules |
69 | ″ | ″ | maximal response |
70 | ″ | ″ | measures |
71 | ″ | ″ | mechanism |
72 | ″ | ″ | migrate |
73 | ″ | ″ | min |
74 | ″ | ″ | modification |
75 | ″ | ″ | non-histone proteins |
76 | ″ | ″ | non-target tissues |
77 | ″ | ″ | nuclear binding |
78 | ″ | ″ | nuclear components |
79 | ″ | ″ | nucleus |
80 | ″ | ″ | only class |
81 | ″ | ″ | oviduct chromatin |
82 | ″ | ″ | oviduct nuclei |
83 | ″ | ″ | patterns |
84 | ″ | ″ | physiological ionic conditions |
85 | ″ | ″ | physiological levels |
86 | ″ | ″ | polymerase |
87 | ″ | ″ | polymerase I |
88 | ″ | ″ | presence |
89 | ″ | ″ | present |
90 | ″ | ″ | progesterone target |
91 | ″ | ″ | progesterone-receptor complex |
92 | ″ | ″ | protein |
93 | ″ | ″ | receptors |
94 | ″ | ″ | respective target cells |
95 | ″ | ″ | response |
96 | ″ | ″ | serum |
97 | ″ | ″ | sites |
98 | ″ | ″ | specificity |
99 | ″ | ″ | steroid hormones |
100 | ″ | ″ | steroid-receptor complex |
101 | ″ | ″ | steroids |
102 | ″ | ″ | strength |
103 | ″ | ″ | target |
104 | ″ | ″ | target cells |
105 | ″ | ″ | tissue |
106 | ″ | ″ | tissue specificity |
107 | ″ | ″ | tissue-specific binding |
108 | ″ | ″ | transcription |
109 | ″ | ″ | vitro10 |
110 | ″ | ″ | vivo |
111 | ″ | ″ | weak affinity |
112 | ″ | ″ | whole chromatin |
113 | ″ | schema:name | Chromosomal proteins regulate steroid binding to chromatin |
114 | ″ | schema:pagination | 65-67 |
115 | ″ | schema:productId | Nb07e9164ea0846b381941874ff8d208a |
116 | ″ | ″ | Nc09c2e3773c248fc9e1d6db124bac641 |
117 | ″ | ″ | Ncd5a5da1179b4c379dca1a3a592c5c83 |
118 | ″ | schema:sameAs | https://app.dimensions.ai/details/publication/pub.1018904914 |
119 | ″ | ″ | https://doi.org/10.1038/262065a0 |
120 | ″ | schema:sdDatePublished | 2022-08-04T16:49 |
121 | ″ | schema:sdLicense | https://scigraph.springernature.com/explorer/license/ |
122 | ″ | schema:sdPublisher | Nb43fac50e665438ca1e378882ed75e86 |
123 | ″ | schema:url | https://doi.org/10.1038/262065a0 |
124 | ″ | sgo:license | sg:explorer/license/ |
125 | ″ | sgo:sdDataset | articles |
126 | ″ | rdf:type | schema:ScholarlyArticle |
127 | N08e8db922bfa4a8dafbdcd475d6a78a5 | schema:inDefinedTermSet | https://www.nlm.nih.gov/mesh/ |
128 | ″ | schema:name | Oviducts |
129 | ″ | rdf:type | schema:DefinedTerm |
130 | N0adcd6bd9b294023b576bed0fda979d6 | schema:inDefinedTermSet | https://www.nlm.nih.gov/mesh/ |
131 | ″ | schema:name | Chickens |
132 | ″ | rdf:type | schema:DefinedTerm |
133 | N3c4763403f4f41a6aaad4ff94e745f96 | rdf:first | sg:person.077352642.31 |
134 | ″ | rdf:rest | Ndecf2995f1534c12b95ffa56b763b7a6 |
135 | N3d62ddc7c16a4c3e90aadb783c25c7ba | schema:inDefinedTermSet | https://www.nlm.nih.gov/mesh/ |
136 | ″ | schema:name | Chromatin |
137 | ″ | rdf:type | schema:DefinedTerm |
138 | N3e5953fb52454b2584a32b3b014608f8 | schema:inDefinedTermSet | https://www.nlm.nih.gov/mesh/ |
139 | ″ | schema:name | Animals |
140 | ″ | rdf:type | schema:DefinedTerm |
141 | N5dcadfd71d174cdfa9431b91699158ff | schema:inDefinedTermSet | https://www.nlm.nih.gov/mesh/ |
142 | ″ | schema:name | Spleen |
143 | ″ | rdf:type | schema:DefinedTerm |
144 | N620555fdc00648c1970b588cad3b4b60 | schema:inDefinedTermSet | https://www.nlm.nih.gov/mesh/ |
145 | ″ | schema:name | Nucleoproteins |
146 | ″ | rdf:type | schema:DefinedTerm |
147 | N62f422f4710a4ca0a4a5435c63f0c109 | schema:inDefinedTermSet | https://www.nlm.nih.gov/mesh/ |
148 | ″ | schema:name | Female |
149 | ″ | rdf:type | schema:DefinedTerm |
150 | N8981a049410d4fc28142fa24d8c7ba4f | schema:inDefinedTermSet | https://www.nlm.nih.gov/mesh/ |
151 | ″ | schema:name | Erythrocytes |
152 | ″ | rdf:type | schema:DefinedTerm |
153 | N8c60740ad9ab44cdb300b32e53bdc225 | rdf:first | sg:person.01113450652.09 |
154 | ″ | rdf:rest | N3c4763403f4f41a6aaad4ff94e745f96 |
155 | N90059206512e4db696aa5522e3e68ee3 | schema:inDefinedTermSet | https://www.nlm.nih.gov/mesh/ |
156 | ″ | schema:name | Binding Sites |
157 | ″ | rdf:type | schema:DefinedTerm |
158 | Nb07e9164ea0846b381941874ff8d208a | schema:name | pubmed_id |
159 | ″ | schema:value | 180427 |
160 | ″ | rdf:type | schema:PropertyValue |
161 | Nb43fac50e665438ca1e378882ed75e86 | schema:name | Springer Nature - SN SciGraph project |
162 | ″ | rdf:type | schema:Organization |
163 | Nc09c2e3773c248fc9e1d6db124bac641 | schema:name | dimensions_id |
164 | ″ | schema:value | pub.1018904914 |
165 | ″ | rdf:type | schema:PropertyValue |
166 | Ncb7e92096e0a4b5fa6ab155f2dafc3f7 | schema:inDefinedTermSet | https://www.nlm.nih.gov/mesh/ |
167 | ″ | schema:name | Deoxyribonucleoproteins |
168 | ″ | rdf:type | schema:DefinedTerm |
169 | Ncd5a5da1179b4c379dca1a3a592c5c83 | schema:name | doi |
170 | ″ | schema:value | 10.1038/262065a0 |
171 | ″ | rdf:type | schema:PropertyValue |
172 | Ndecf2995f1534c12b95ffa56b763b7a6 | rdf:first | sg:person.0103213742.25 |
173 | ″ | rdf:rest | rdf:nil |
174 | Ne08f99392e914c8496d4a792c41164c1 | schema:volumeNumber | 262 |
175 | ″ | rdf:type | schema:PublicationVolume |
176 | Ne42f33d5b31043faa93bc8c9f4be8b17 | schema:issueNumber | 5563 |
177 | ″ | rdf:type | schema:PublicationIssue |
178 | Nf1ebb43768b648c88254d0ae4a162ebc | schema:inDefinedTermSet | https://www.nlm.nih.gov/mesh/ |
179 | ″ | schema:name | Receptors, Cell Surface |
180 | ″ | rdf:type | schema:DefinedTerm |
181 | Nf4580ad608f6411f8a9a49573d70a682 | schema:inDefinedTermSet | https://www.nlm.nih.gov/mesh/ |
182 | ″ | schema:name | Progesterone |
183 | ″ | rdf:type | schema:DefinedTerm |
184 | anzsrc-for:06 | schema:inDefinedTermSet | anzsrc-for: |
185 | ″ | schema:name | Biological Sciences |
186 | ″ | rdf:type | schema:DefinedTerm |
187 | anzsrc-for:0601 | schema:inDefinedTermSet | anzsrc-for: |
188 | ″ | schema:name | Biochemistry and Cell Biology |
189 | ″ | rdf:type | schema:DefinedTerm |
190 | anzsrc-for:11 | schema:inDefinedTermSet | anzsrc-for: |
191 | ″ | schema:name | Medical and Health Sciences |
192 | ″ | rdf:type | schema:DefinedTerm |
193 | anzsrc-for:1103 | schema:inDefinedTermSet | anzsrc-for: |
194 | ″ | schema:name | Clinical Sciences |
195 | ″ | rdf:type | schema:DefinedTerm |
196 | sg:journal.1018957 | schema:issn | 0028-0836 |
197 | ″ | ″ | 1476-4687 |
198 | ″ | schema:name | Nature |
199 | ″ | schema:publisher | Springer Nature |
200 | ″ | rdf:type | schema:Periodical |
201 | sg:person.0103213742.25 | schema:affiliation | grid-institutes:grid.66875.3a |
202 | ″ | schema:familyName | PIKLER |
203 | ″ | schema:givenName | GEORGE M. |
204 | ″ | schema:sameAs | https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0103213742.25 |
205 | ″ | rdf:type | schema:Person |
206 | sg:person.01113450652.09 | schema:affiliation | grid-institutes:grid.66875.3a |
207 | ″ | schema:familyName | SPELSBERG |
208 | ″ | schema:givenName | THOMAS C. |
209 | ″ | schema:sameAs | https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01113450652.09 |
210 | ″ | rdf:type | schema:Person |
211 | sg:person.077352642.31 | schema:affiliation | grid-institutes:grid.66875.3a |
212 | ″ | schema:familyName | WEBSTER |
213 | ″ | schema:givenName | ROBERT A. |
214 | ″ | schema:sameAs | https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.077352642.31 |
215 | ″ | rdf:type | schema:Person |
216 | grid-institutes:grid.66875.3a | schema:alternateName | Department of Molecular Medicine, Mayo Clinic and Graduate School of Medicine, 55901, Rochester, Minnesota |
217 | ″ | schema:name | Department of Molecular Medicine, Mayo Clinic and Graduate School of Medicine, 55901, Rochester, Minnesota |
218 | ″ | rdf:type | schema:Organization |